
IndraLab
Statements
BAP1 inhibits Neoplasm Metastasis. 31 / 31
|
31
reach
"19 However, GNA11 mutations are also more common in tumors involving the ciliary body, which is an independent risk factor for metastasis, and in tumors with mutations in the metastasis suppressor BAP1 (Breast cancer 1, early onset (BRCA1)-associated protein 1) (see below), so it remains possible or even likely that the association between GNA11 and metastasis is not causal."
reach
"While we and others have extensively investigated the downstream effects of BAP1 loss in UM cells [5,6,7], the mechanism by which BAP1 loss leads to metastasis remains unclear.Despite the increasingly effective management of primary UM, there has been no corresponding improvement in patient survival [8], due to a propensity for early micrometastasis and immune escape [9]."
reach
"Given this interplay between the liver's lipid‐rich microenvironment and the role of fatty acid metabolism in ferroptosis, we hypothesize that BAP1 loss contributes to the successful metastasis of UM through unique management of the lipid‐rich liver microenvironment, thus providing insights to UM's hepatic organotropism.Understanding the interactions between UM cells and the hepatic microenvironment is essential for developing novel treatment approaches."
reach
"Of note, knockdown of BAP1 promoted intrahepatic tumor metastasis, with both BAP1 knockdown groups (shBAP1#1 and shBAP1#3) showing more frequent irregular tumor borders with invasion into the adjacent liver parenchyma, more frequent tumor microsatellite formation and venous invasion (Fig. 3C, D)."